Jacobs Bruce N. - Insider Stock Trading

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	Qty	oc	Own	H
6/28/24 08:30	6/27/24	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	M.d	52	2.08	25	17	169	D
3/4/24 18:12	3/4/24	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	S.d	-165	41.86	-4	-3	142	D
6/2/23 14:17	6/2/23	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	M.d	21	2.08	10	10	115	D
3/3/23 16:30	3/2/23	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	S.d	-42	31.00	-1	-1	105	D
10/24/22 08:00	10/21/22	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	M.d	21	2.08	10	14	81	D
10/17/22 20:12	10/17/22	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	M.d	21	2.08	10	16	71	D
5/3/22 19:26	5/3/22	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	M.d	42	2.08	20	49	61	D
1/14/22 17:15	1/14/22	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	M.d	21	2.08	10	57	28	D
1/14/22 17:01	1/12/22	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	S.d	-778	51.85	-15	-46	18	D
1/14/22 17:01	1/12/22	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	M.d	31	2.08	15	597	18	D
12/3/21 18:43	12/3/21	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	M.d	21	2.08	10	133	18	D
12/3/21 18:43	12/3/21	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	S.d	-536	53.56	-10	-36	18	D
11/23/21 16:59	11/23/21	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	M.d	21	2.08	10	138	17	D
9/3/21 17:57	9/3/21	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	S.d	-601	60.12	-10	-58	7	D
9/3/21 17:57	9/3/21	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	M.d	21	2.08	10		7	D
6/4/21 16:16	6/3/21	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	S.d	-469	46.87	-10	-58	7	D
6/4/21 16:16	6/3/21	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	M.d	21	2.08	10		7	D
4/13/21 18:37	4/13/21	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	M.d	15	2.08	7	New	7	D
3/15/21 21:08	3/11/21	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	S.dm	-602	60.15	-10	-100	0	D
3/15/21 21:08	3/11/21	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	M.dm	21	2.08	10		0	D
3/8/21 20:01	3/8/21	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	S.d	-506	50.65	-10	-100	0	D
3/8/21 20:01	3/8/21	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	M.d	21	2.08	10		0	D
3/5/21 17:26	3/3/21	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	M.d	42	2.08	20		0	D
3/5/21 17:26	3/3/21	KYMR	Kymera Therapeutics, Inc.	DE	Health	BioPrd	Biological Products, (No Diag	Jacobs Bruce N.	MA	O	CFO	S.d	-896	44.78	-20	-100	0	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y